Nanotechnology Now

Our NanoNews Digest Sponsors


Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > ULURU Inc. Announces Development Partnership With a Leading Consumer Pharmaceutical Company to Develop a Range of Products.

Abstract:
- Initial development focused on utilizing our nanoparticle elastic gel to improve topical product performance -

ULURU Inc. Announces Development Partnership With a Leading Consumer Pharmaceutical Company to Develop a Range of Products.

ADDISON, TX | Posted on July 11th, 2007

ULURU Inc. (OTC Bulletin Board: ULUR) today announced that it has commenced the development of a range of consumer pharmaceutical products under a development agreement signed with a major consumer pharmaceutical company.

The initial developments are focused on utilizing our nanoparticle
elastic adhesive gel, which offers the potential to significantly extend
the time that a flexible film stays in contact with the skin, to release
active compounds. Under the terms of the agreement ULURU will receive
payments for the development activities and has granted its development
partner a period of exclusivity to enter a potential licensing agreement.

Commenting on the agreement Kerry P. Gray, President and CEO of ULURU
Inc., stated "This is an important validation of our nanoparticle elastic
gel technology. Considerable interest has been expressed in this technology
by both consumer product and dermatology companies as the gel offers the
potential to extend the delivery of actives to the skin surface. Both the
gel technology and our erodible film technology give us the potential to
develop a range of differentiated consumer pharmaceutical products with a
significant period of patent protection. We continue to explore extensions
of our technology applications into the consumer pharmaceutical market as
this offers the potential to accelerate product revenue."

The nanoparticle elastic gel forms a transparent adhesive film that can
be spread on intact skin or superficial non-exudating wounds. The film can
be applied to irregular surfaces such as joints without impairing movement
and deliver active compounds for extended periods of time. Potential uses
of the elastic gel include treatment of acne, psoriasis, skin irritation,
scar management and cold sores.

####

About ULURU Inc.
ULURU Inc. is an emerging specialty pharmaceutical company focused on
the development of a portfolio of wound management, plastic surgery and
oral care products to provide patients and consumers improved clinical
outcomes through controlled delivery utilizing its innovative transmucosal
delivery system and Hydrogel Nanoparticle Aggregate technology. For further
information about ULURU Inc., please visit our website at
http://www.uluruinc.com .

This press release contains certain statements that are forward-looking
within the meaning of Section 27a of the Securities Act of 1933, as
amended, including but not limited to statements made relating to potential
licensing arrangements, potential uses for our nanoparticle elastic gel
technology, interest expressed in this technology, and the potential for
accelerated product revenue. These statements are subject to numerous risks
and uncertainties, including but not limited to the risk factors detailed
in the Company's Annual Report on Form 10-KSB for the year ended December
31, 2006, Quarterly Report on Form 10-QSB for the quarter ended March 31,
2007 and other reports filed by us with the Securities and Exchange
Commission.

For more information, please click here

Contacts:
Kerry P. Gray
President & CEO
Terry K. Wallberg
Vice President & CFO
(214) 905-5145

Copyright © PR Newswire Association LLC.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Nanomedicine

Radiation-guided nanoparticles zero in on metastatic cancer July 1st, 2016

A drop of water as a model for the interplay of adhesion and stiction June 30th, 2016

How cancer cells spread and squeeze through tiny blood vessels (video) June 30th, 2016

Building a smart cardiac patch: 'Bionic' cardiac patch could one day monitor and respond to cardiac problems June 28th, 2016

Announcements

Radiation-guided nanoparticles zero in on metastatic cancer July 1st, 2016

Synthesized microporous 3-D graphene-like carbons: IBS research team create carbon synthesis using zeolites as a template July 1st, 2016

No need in supercomputers: Russian scientists suggest a PC to solve complex problems tens of times faster than with massive supercomputers June 30th, 2016

Surprising qualities of insulator ring surfaces: Surface phenomena in ring-shaped topological insulators are just as controllable as those in spheres made of the same material June 30th, 2016

Alliances/Trade associations/Partnerships/Distributorships

FEI and University of Liverpool Announce QEMSCAN Research Initiative: University of Liverpool will utilize FEIís QEMSCAN technology to gain a better insight into oil and gas reserves & potentially change the approach to evaluating them June 22nd, 2016

French Research Team Helps Extend MRI Detection of Diseases & Lower Health-Care Costs: CEA, INSERM and G2ELab Brings Grenoble Regionís Expertise In Advanced Medicine & Magnetism Applications to H2020 IDentIFY Project June 21st, 2016

Research showing why hierarchy exists will aid the development of artificial intelligence June 13th, 2016

UK NANOSAFETY GROUP publishes 2nd Edition of guidance to support safe working with nanomaterials May 30th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







Car Brands
Buy website traffic